---
title: "Kingdomway's subsidiary has obtained the approval number for veterinary drug products"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256703591.md"
description: "According to the Zhitong Finance APP, Kingdomway announced that its holding subsidiary, Jiangsu Chengxin Pharmaceutical Co., Ltd., recently received the veterinary drug product approval number issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. Generic name: Praziquantel, veterinary drug product approval number: Veterinary Drug Original Character 102091173"
datetime: "2025-09-10T09:10:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256703591.md)
  - [en](https://longbridge.com/en/news/256703591.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256703591.md)
generator: "portal-rs"
---

# Kingdomway's subsidiary has obtained the approval number for veterinary drug products

According to the Zhitong Finance APP, Kingdomway (002626.SZ) announced that its controlling subsidiary, Jiangsu Chengxin Pharmaceutical Co., Ltd., recently received the veterinary drug product approval number issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. Generic name: Praziquantel, veterinary drug product approval number: Veterinary Drug Original Character 102091173

### Related Stocks

- [002626.CN](https://longbridge.com/en/quote/002626.CN.md)

## Related News & Research

- [Odfjell Technology (OB:OTL) Stock Faces A Bigger Margin Question](https://longbridge.com/en/news/296647267.md)
- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [Orkla Non-GAAP EPS of NOK 1.60, revenue of NOK 16.7B](https://longbridge.com/en/news/296456178.md)
- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [Zaptec insider-linked company buys shares worth NOK 12.36 million](https://longbridge.com/en/news/296378460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**